Pacer Advisors Inc. Boosts Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Pacer Advisors Inc. boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 85.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,763 shares of the biotechnology company's stock after purchasing an additional 4,509 shares during the quarter. Pacer Advisors Inc.'s holdings in Axon Enterprise were worth $5,802,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of AXON. Quent Capital LLC grew its holdings in shares of Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company's stock valued at $32,000 after purchasing an additional 75 shares during the last quarter. Prestige Wealth Management Group LLC grew its stake in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock worth $33,000 after buying an additional 44 shares during the last quarter. Versant Capital Management Inc increased its holdings in shares of Axon Enterprise by 4,750.0% during the fourth quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock worth $58,000 after buying an additional 95 shares in the last quarter. Berbice Capital Management LLC bought a new position in shares of Axon Enterprise in the 4th quarter valued at $59,000. Finally, Brooklyn Investment Group acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at $41,000. Institutional investors own 79.08% of the company's stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 21,834 shares of the business's stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the sale, the insider now directly owns 154,394 shares of the company's stock, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Joshua Isner sold 20,000 shares of the firm's stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the transaction, the president now owns 208,166 shares in the company, valued at $126,179,820.90. This represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock valued at $30,721,337 over the last ninety days. 6.10% of the stock is owned by company insiders.

Axon Enterprise Stock Up 2.1 %

Axon Enterprise stock traded up $13.46 during midday trading on Thursday, reaching $653.43. The stock had a trading volume of 533,702 shares, compared to its average volume of 565,376. The company has a fifty day moving average price of $618.90 and a two-hundred day moving average price of $477.78. The company has a market capitalization of $49.82 billion, a P/E ratio of 168.85, a PEG ratio of 6.09 and a beta of 1.04. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $247.04 and a 12 month high of $698.67.

Analyst Ratings Changes

AXON has been the subject of several research reports. JMP Securities increased their target price on Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a research report on Thursday, October 31st. Morgan Stanley upgraded shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and upped their price target for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Northland Securities lifted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a report on Monday, November 11th. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective for the company. Finally, Needham & Company LLC raised their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a research report on Friday, November 8th. One investment analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus price target of $524.85.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.